Suvn 502: Latest News on Suvn 502, Suvn 502 Updates, Suvn 502 Videos, Photos, Wiki, Topic

Share >

Share on Tumblr

Suvn 502

News »
latest by relevance

Suven Life gears up for phase-2 trial of Alzheimer's drug

May 18, 2011 at 15:26 | Source: CNBC-TV18

Venkat Jasti, CEO of Suven Life Sciences says that the company is now preparing for the next level phase-2 of clinical trial, for its molecule that will help treatment of Alzheimer's disease and schizophrenia.

Suven Life completes phase I trail for Alzheimer drug

May 18, 2011 at 11:48 | Source: Moneycontrol.com

Suven Life Science successfully completed Alzheimer drug, Suvn-502, phase I clinical trails and said it is filing for Investigational New Drug application with the US Food and Drug Administration.

Talking to 3 major pharma cos for a JV: Suven Life

Sep 09, 2010 at 15:51 | Source: CNBC-TV18

Suven Life Sciences has secured two product patents, one each in Australia and Mexico. In an interview with CNBC-TV18's Latha Venkatesh and Reema Tendulkar, Venkat Jasti, CEO, Suven Life Sciences spoke on the company's business plans going forward.

See 25% growth in CRAMS biz next year: Suven Life Sciences

Mar 19, 2010 at 17:19 | Source: CNBC-TV18

In an interview with CNBC-TV18, Venkat Jasti, Chief Executive Officer of Suven Life Sciences, spoke about his outlook for the company.

Suven Life Sciences files 39 product patents

Dec 18, 2006 at 17:26

MD of Suven Life Sciences, Venkat Jasti expects to end the financial year with Rs 105-110 crore of sales and Rs 15 crore net profits after spending about Rs 16 crore in the R&D. He gives the company's plans and targets going forward.

Interact & exchange stock tips & market info »

difley

Silver Member

4 Followers

Suven Life Scie

Suven Life Sciences Ltd.`s Alzheimer Drug Candidate SUVN-502...

12.36 PM Sep 27th 2011

Related News »

Suven Life Sciences Ltd. : Suven Life Sciences secures 4 Product Patents for their NCEs in Japan, Australia, Europe and Eurasia

Parkinson's disease and obesity in addition to developmental candidate SUVN-502 for Alzheimer's disease and Schizophrenia. Except for historical information, all of the statements, expectations and assumptions, including expectations and assumptions ...

May 22, 2012 at 08:15 | Source: 4-traders (press release)

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window

Explore Moneycontrol

STOCKS A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others

MUTUAL FUNDS A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.

Suvn 502

News »

Videos »

Photos »

Follow moneycontrol.com

Explore Moneycontrol